JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

The Johns Hopkins Heartburn Center Registry

Conditions: Barrett Esophagus
Laryngopharyngeal Reflux
Gastroesophageal Reflux Disease
Esophagitis

First Posted Date: 2019-02-26

Last Posted Date: 2025-03-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 2000

Registration Number: NCT03853772

Locations: 🇺🇸
UCI-Irvine, Orange, California, United States
🇺🇸
The Matagorda Regional Medical Group, Bay City, Texas, United States
🇺🇸
UT Health, Houston, Texas, United States

and more 6 locations

Safely Disposing of Surplus Prescription Opioids

Not Applicable

Completed

Conditions: Opioid Use

Interventions: Behavioral: Informational Sheet
Behavioral: DisposeRx Drug Disposal kit

First Posted Date: 2019-02-26

Last Posted Date: 2019-09-23

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 499

Registration Number: NCT03855241

Locations: 🇺🇸
Johns Hopkins Hospital/Johns Hopkins Outpatient Center, Baltimore, Maryland, United States

Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation

Not Applicable

Completed

Conditions: Mild Traumatic Brain Injury
Vestibular Neuropathy

Interventions: Device: Incremental Velocity Error (IVE)
Behavioral: Traditional Vestibular Rehabilitation (VPT)

First Posted Date: 2019-02-20

Last Posted Date: 2025-05-08

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 24

Registration Number: NCT03846830

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Fort Belvoir CH, Fort Belvoir, Virginia, United States

CryoBalloon Ablation for Treatment of Duodenal Adenomas

Not Applicable

Active, not recruiting

Conditions: Duodenal Adenomas
Familial Adenomatous Polyposis

Interventions: Device: CryoBalloon ablation

First Posted Date: 2019-02-20

Last Posted Date: 2025-03-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 44

Registration Number: NCT03847636

Locations: 🇺🇸
Northwell Health, Manhasset, New York, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Geisinger Medical Center, Danville, Pennsylvania, United States

and more 1 locations

Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH

Not Applicable

Recruiting

Conditions: Alcohol Use Disorder
Alcoholic Hepatitis

Interventions: Behavioral: Integrated AUD Treatment

First Posted Date: 2019-02-19

Last Posted Date: 2023-09-28

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 200

Registration Number: NCT03845205

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

Escitalopram and Language Intervention for Subacute Aphasia

Phase 2

Recruiting

Conditions: Stroke
Aphasia

Interventions: Drug: Placebo
Drug: Escitalopram 10mg
Behavioral: Computer-delivered naming treatment

First Posted Date: 2019-02-18

Last Posted Date: 2024-11-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 88

Registration Number: NCT03843463

Locations: 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
🇺🇸
University of South Carolina, Columbia, South Carolina, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Tencel vs. Standard Cotton Therapeutic Garments as an Adjunct Treatment for Moderate to Severe Atopic Dermatitis in Children

Not Applicable

Withdrawn

Conditions: Atopic Dermatitis

Interventions: Device: Cotton Therapeutic Garments
Device: Tencel Therapeutic Garments

First Posted Date: 2019-02-18

Last Posted Date: 2022-08-26

Lead Sponsor: Johns Hopkins University

Registration Number: NCT03843437

Locations: 🇺🇸
Johns Hopkins Pediatric Dermatology Clinic, Baltimore, Maryland, United States

Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)

Phase 1

Withdrawn

Conditions: Pregnancy
HIV-1-infection

Interventions: Drug: Standard dose Truvada®
Drug: Pregnancy-adjusted dose Truvada®

First Posted Date: 2019-02-08

Last Posted Date: 2022-04-06

Lead Sponsor: Johns Hopkins University

Registration Number: NCT03834909

Behavioral and Physiological Effects of THC and CBD

Phase 1

Withdrawn

Conditions: Healthy Volunteers

Interventions: Drug: Vaporized CBD with THC
Drug: Placebo
Drug: Vaporized THC alone
Drug: Vaporized CBD alone

First Posted Date: 2019-02-06

Last Posted Date: 2019-08-05

Lead Sponsor: Johns Hopkins University

Registration Number: NCT03832816

Locations: 🇺🇸
Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States

Steroid-reducing Effects of Crisaborole

Phase 4

Completed

Conditions: Atopic Dermatitis
Eczema

Interventions: Drug: Crisaborole
Drug: Hydrocortisone Ointment
Drug: Triamcinolone ointment
Drug: Aquaphor

First Posted Date: 2019-02-06

Last Posted Date: 2024-07-19

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 24

Registration Number: NCT03832010

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy